Shoulder Innovations Launches InSet™ 70 Humeral Stem for Joint Care
Shoulder Innovations Launches InSet™ 70 Humeral Stem
In a significant development for the field of shoulder surgery, Shoulder Innovations, Inc. (NYSE: SI) has officially unveiled the InSet™ 70 Humeral Stem. This launch represents the latest addition to the company's I-Series product line, complementing the previously introduced InSet™ 95 stem from 2024. The InSet™ 70 is designed to meet a wide range of clinical needs, making it a versatile option for both surgical professionals and patients alike.
Rob Ball, the CEO of Shoulder Innovations, expressed enthusiasm about bringing this innovative product to market ahead of schedule. "The InSet™ 70 complements our broad portfolio of advanced shoulder implant solutions, and we are excited to bring it to market across the United States ahead of schedule," he stated. This release is seen as a testament to the company’s commitment to enhancing the quality of care through innovative technology and effective surgical solutions.
The InSet™ 70 is indicated for both anatomic and reverse shoulder arthroplasties. It addresses various clinical issues, including non-inflammatory degenerative joint diseases like osteoarthritis, avascular necrosis, rheumatoid arthritis, and traumatic arthritis. Additionally, it is particularly suited for reverse procedures related to irreparable cuff tears, as well as revisions of other devices when adequate bone stock is present.
Dr. Galen Kam highlighted the benefits of the InSet™ 70, noting that it offers the same excellent initial fixation and streamlined workflow as the longer InSet™ 95 variant. However, the InSet™ 70 also possesses the added advantage of preserving bone, which is crucial in surgical procedures. This innovative design is expected to contribute positively to patient outcomes, providing a compelling option for those requiring shoulder surgery.
Dr. Matthew Pifer echoed these sentiments, stating, "The InSet™ 70 provides my patients with superb humeral fixation within the reverse total shoulder platform, delivering optimized biomechanics and supporting improved shoulder function." This endorsement from practicing surgeons underlines the product's potential to enhance postoperative recovery and functionality for patients.
Shoulder Innovations is at the forefront of transforming shoulder surgical care, focusing on preoperative planning, implant design, and procedural efficiency. Their ecosystem integrates cutting-edge technologies, efficient instrument systems, and specialized support, which together tackle long-standing challenges in shoulder surgery. The company aims to deliver predictable outcomes and procedural simplicity across various care settings, ensuring that both surgeons and their patients benefit from these advancements.
As Shoulder Innovations continues to expand its offerings in shoulder arthroplasty, the InSet™ 70 Humeral Stem stands as a significant milestone in their ongoing mission to revolutionize the surgical care market. Its introduction is expected not only to enhance the company's product lineup but also to improve the overall quality of shoulder surgeries performed nationwide, ultimately leading to better health outcomes for patients.